{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:43:27Z","timestamp":1785786207491,"version":"3.56.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA049953"],"award-info":[{"award-number":["DA049953"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.josat.2022.208950","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T05:22:54Z","timestamp":1673587374000},"page":"208950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Facilitators and barriers to collaboration between drug courts and community-based medication for opioid use disorder providers"],"prefix":"10.1016","volume":"147","author":[{"given":"Ekaterina","family":"Pivovarova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faye S.","family":"Taxman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra K.","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Smelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephenie C.","family":"Lemon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Friedmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.josat.2022.208950_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40352-022-00188-4","article-title":"Barriers to medications for opioid use disorder in the court system: Provider availability, provider \u201ctrustworthiness\u201d, and cost","volume":"10","author":"Ahmed","year":"2022","journal-title":"Health & Justice"},{"key":"10.1016\/j.josat.2022.208950_bb0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jsat.2019.12.004","article-title":"Assessing the impact of drug courts on provider-directed marketing efforts by manufactures of medications for the treatment of opioid use disorder","volume":"110","author":"Andraka-Christou","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"12","key":"10.1016\/j.josat.2022.208950_bb0015","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1111\/add.15077","article-title":"The association of criminal justice supervision setting with overdose mortality: A longitudinal cohort study","volume":"115","author":"Binswanger","year":"2020","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.josat.2022.208950_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1940-0640-7-3","article-title":"Return to drug use and overdose after release from prison: A qualitative study of risk and protective factors","volume":"7","author":"Binswanger","year":"2012","journal-title":"Addiction Science & Clinical Practice"},{"issue":"2","key":"10.1016\/j.josat.2022.208950_bb0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMsa064115","article-title":"Release from prison\u2014A high risk of death for former inmates","volume":"356","author":"Binswanger","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.josat.2022.208950_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7517-10-35","article-title":"Methadone treatment providers'views of drug court policy and practice: A case study of New York State","volume":"10","author":"Csete","year":"2013","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2022.208950_bb0035","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: A consolidated framework for advancing implementation science","volume":"4","author":"Damschroder","year":"2009","journal-title":"Implementation Science"},{"issue":"2","key":"10.1016\/j.josat.2022.208950_bb0040","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1037\/a0022284","article-title":"A guiding framework and approach for implementation research in substance use disorders treatment","volume":"25","author":"Damschroder","year":"2011","journal-title":"Psychology of Addictive Behaviors"},{"key":"10.1016\/j.josat.2022.208950_bb0045","author":"Dedoose"},{"key":"10.1016\/j.josat.2022.208950_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108277","article-title":"Stepped-wedge randomized controlled trial of a novel opioid court to improve identification of need and linkage to medications for opioid use disorder treatment for court-involved adults","volume":"128","author":"Elkington","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2022.208950_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109254","article-title":"Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder","volume":"231","author":"Evans","year":"2022","journal-title":"Drug Alcohol Dependence"},{"key":"10.1016\/j.josat.2022.208950_bb0060","article-title":"Medication-assisted treatment in problem-solving courts: A national survey of state and local court coordinators","volume":"00220426221109948","author":"Farago","year":"2022","journal-title":"Journal of Drug Issues"},{"issue":"1","key":"10.1016\/j.josat.2022.208950_bb0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13012-018-0736-7","article-title":"Developing measures to assess constructs from the inner setting domain of the consolidated framework for implementation research","volume":"13","author":"Fernandez","year":"2018","journal-title":"Implementation Science"},{"issue":"9","key":"10.1016\/j.josat.2022.208950_bb0070","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s11606-020-05944-6","article-title":"Barriers to medications for opioid use disorder among veterans involved in the legal system: A qualitative study","volume":"35","author":"Finlay","year":"2020","journal-title":"Journal of General Internal Medicine"},{"issue":"1","key":"10.1016\/j.josat.2022.208950_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2194-7899-1-6","article-title":"A cluster randomized trial of an organizational linkage intervention for offenders with substance use disorders: Study protocol","volume":"1","author":"Friedmann","year":"2013","journal-title":"Health & Justice"},{"issue":"1","key":"10.1016\/j.josat.2022.208950_bb0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08897077.2011.611460","article-title":"Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): Availability, barriers, and intentions","volume":"33","author":"Friedmann","year":"2012","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2022.208950_bb6000","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jsat.2014.10.001","article-title":"Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community corrections","volume":"50","author":"Friedmann","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.josat.2022.208950_bb0085","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/01488376.2018.1472173","article-title":"Improving graduation rates in drug court through employment and schooling opportunities and medication-assisted treatment (MAT)","volume":"44","author":"Gallagher","year":"2018","journal-title":"Journal of Social Service Research"},{"issue":"6","key":"10.1016\/j.josat.2022.208950_bb0090","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/bsl.1015","article-title":"Medication-assisted treatment research with criminal justice populations: Challenges of implementation","volume":"29","author":"Gordon","year":"2011","journal-title":"Behavioral Sciences & the Law"},{"issue":"6","key":"10.1016\/j.josat.2022.208950_bb0095","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/0033354918803938","article-title":"Linking opioid-overdose data to human services and criminal justice data: Opportunities for intervention","volume":"133","author":"Hacker","year":"2018","journal-title":"Public Health Reports"},{"key":"10.1016\/j.josat.2022.208950_bb0100","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fpubh.2018.00190","article-title":"Unpacking partnership, engagement, and collaboration research to inform implementation strategies development: Theoretical frameworks and emerging methodologies","volume":"6","author":"Huang","year":"2018","journal-title":"Frontiers in Public Health"},{"key":"10.1016\/j.josat.2022.208950_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108881","article-title":"Structural and organizational factors shaping access to medication treatment for opioid use disorder in community supervision","volume":"226","author":"Kennedy-Hendricks","year":"2021","journal-title":"Drug Alcohol Dependence"},{"issue":"10118","key":"10.1016\/j.josat.2022.208950_bb0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X: BOT): A multicentre, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.josat.2022.208950_bb0115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13012-021-01090-7","article-title":"A systematic review of evidence-based practice implementation in drug and alcohol settings: Applying the consolidated framework for implementation research framework","volume":"16","author":"Louie","year":"2021","journal-title":"Implement Science"},{"key":"10.1016\/j.josat.2022.208950_bb0120","series-title":"Painting the current picture: A national report on drug courts and other problem-solving courts in the United States","author":"Marlowe","year":"2016"},{"key":"10.1016\/j.josat.2022.208950_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108850","article-title":"Drug court utilization of medications for opioid use disorder in high opioid mortality communities","volume":"141","author":"Marlowe","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2022.208950_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103823","article-title":"Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts","volume":"109","author":"Matsumoto","year":"2022","journal-title":"International Journal of Drug Policy"},{"issue":"5","key":"10.1016\/j.josat.2022.208950_bb0140","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jsat.2012.10.004","article-title":"Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes","volume":"44","author":"Matusow","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"10","key":"10.1016\/j.josat.2022.208950_bb0145","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1080\/10826084.2021.1936045","article-title":"Online medication assisted treatment education for court professionals: Need, opportunities and challenges","volume":"56","author":"Matusow","year":"2021","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.josat.2022.208950_bb0150","series-title":"Adult drug court best practice standards","year":"2013"},{"key":"10.1016\/j.josat.2022.208950_bb0155","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.drugalcdep.2018.04.034","article-title":"Beyond the walls: Risk factors for overdose mortality following release from the Philadelphia Department of Prisons","volume":"189","author":"Pizzicato","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2022.208950_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13012-015-0209-1","article-title":"A refined compilation of implementation strategies: Results from the expert recommendations for implementing change (ERIC) project","volume":"10","author":"Powell","year":"2015","journal-title":"Implementation Science"},{"issue":"5","key":"10.1016\/j.josat.2022.208950_bb0165","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/ajad.13208","article-title":"Substance use treatment services utilization and outcomes among probationers in drug courts compared to a matched cohort of probationers in traditional courts","volume":"30","author":"Rodriguez-Monguio","year":"2021","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.josat.2022.208950_bb0170","article-title":"Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers","volume":"103803","author":"Stopka","year":"2022","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2022.208950_bb0175","series-title":"Grounded theory in practice","author":"Strauss","year":"1997"},{"issue":"12\u201313","key":"10.1016\/j.josat.2022.208950_bb0180","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1081\/JA-120014426","article-title":"Treatment inside the drug treatment court: The who, what, where, and how of treatment services","volume":"37","author":"Taxman","year":"2002","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.josat.2022.208950_bb0185","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.drugalcdep.2009.01.008","article-title":"Availability and capacity of substance abuse programs in correctional settings: A classification and regression tree analysis","volume":"103","author":"Taxman","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.josat.2022.208950_bb0190","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"International Journal for Quality in Health Care"},{"key":"10.1016\/j.josat.2022.208950_bb0195","series-title":"Drug Courts Flyer","year":"2021"},{"issue":"1","key":"10.1016\/j.josat.2022.208950_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13012-019-0892-4","article-title":"Choosing implementation strategies to address contextual barriers: Diversity in recommendations and future directions","volume":"14","author":"Waltz","year":"2019","journal-title":"Implementation Science"},{"issue":"593","key":"10.1016\/j.josat.2022.208950_bb0205","doi-asserted-by":"crossref","first-page":"e772","DOI":"10.3399\/bjgp11X613106","article-title":"Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): A randomised controlled trial","volume":"61","author":"Wright","year":"2011","journal-title":"British Journal of General Practice"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875922000212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875922000212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:49:23Z","timestamp":1757432963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875922000212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":41,"alternative-id":["S2949875922000212"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2022.208950","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Facilitators and barriers to collaboration between drug courts and community-based medication for opioid use disorder providers","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2022.208950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"208950"}}